Literature DB >> 759205

A comparison of the inhibitory effect of cinnarizine and papaverine on the noradrenaline- and calcium-evoked contraction of isolated rabbit aorta and mesenteric arteries.

A Broekaert, T Godfraind.   

Abstract

The inhibitory effects of cinnarizine and papaverine on the noradrenaline- and Ca-induced contraction of the rabbit thoracic aorta and mesenteric arteries have been compared. Papaverine was equally effective in reducing the contractile response evoked from both thoracic aorta and mesenteric arteries by the two modes of stimulation. Cinnarizine blocked the Ca-evoked contraction of the depolarized vessels but was less effective against the noradrenaline-induced contraction of the mesenteric arteries and even failed to antagonize the response of the thoracic aorta to noradrenaline. In Ca-free medium noradrenaline (10-5 M) evoked a fast non-sustained contraction. After readmission of CaCl2 a slow sustained contraction developed. In mesenteric arteries exposed to noradrenaline, cinnarizine selectively blocked the Ca0 dependent response while papaverine inhibited the initial fast response more than the Ca0 dependent one. These results suggest that cinnarizine and papaverine antagonize vascular contraction by different mechanisms. Cinnarizine seems to act by reducing membrane permeability to extracellular calcium. Papaverine inhibits the contraction by a main action on intracellular sequestration of activator calcium and to a lesser degree by an action similar to that of cinnarizine.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 759205     DOI: 10.1016/0014-2999(79)90134-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

1.  Vasorelaxant and antihypertensive effects of formononetin through endothelium-dependent and -independent mechanisms.

Authors:  Tao Sun; Rui Liu; Yong-xiao Cao
Journal:  Acta Pharmacol Sin       Date:  2011-08       Impact factor: 6.150

2.  Enhanced reactivity towards flunarizine in cerebrovascular bed of spontaneously hypertensive rats.

Authors:  E Koźniewska
Journal:  Experientia       Date:  1988-03-15

3.  Studies on the calcium antagonistic action of tetrandrine: VII. Effects of tetrandrine on contractility of isolated rat uterus.

Authors:  D C Fang; W X Yao; J L Zhao; M X Jiang
Journal:  Acta Acad Med Wuhan       Date:  1984

4.  [Studies on the calcium antagonistic action of tetrandrine: IX. Effects of tetrandrine on the contractility of isolated swine coronary artery strips].

Authors:  J F Jia; N N Gao; G J Xia; Q F Luo; D C Fang; M X Jiang
Journal:  Acta Acad Med Wuhan       Date:  1985

5.  Histamine modulates contraction and cyclic nucleotides in cultured rat mesangial cells. Differential effects mediated by histamine H1 and H2 receptors.

Authors:  J R Sedor; H E Abboud
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

6.  Effects of five different organic calcium antagonists on guinea-pig isolated trachea.

Authors:  C Advenier; J Cerrina; P Duroux; A Floch; A Renier
Journal:  Br J Pharmacol       Date:  1984-07       Impact factor: 8.739

7.  Vasorelaxant effect of diterpenoid lactones from Andrographis paniculata chloroform extract on rat aortic rings.

Authors:  R N Sriramaneni; Ameer Z Omar; Salman M Ibrahim; Sadikun Amirin; Asmawi Mohd Zaini
Journal:  Pharmacognosy Res       Date:  2010-07

8.  Effect of Cymbopogon citratus and Citral on Vascular Smooth Muscle of the Isolated Thoracic Rat Aorta.

Authors:  R Chitra Devi; S M Sim; R Ismail
Journal:  Evid Based Complement Alternat Med       Date:  2012-05-22       Impact factor: 2.629

Review 9.  Recent advances in delivery systems and therapeutics of cinnarizine: a poorly water soluble drug with absorption window in stomach.

Authors:  Smita Raghuvanshi; Kamla Pathak
Journal:  J Drug Deliv       Date:  2014-11-13

10.  Vasorelaxant effects of Angelica decursiva root on isolated rat aortic rings.

Authors:  Bumjung Kim; Youngki Kwon; Somin Lee; Kyungjin Lee; Inhye Ham; Ho-Young Choi
Journal:  BMC Complement Altern Med       Date:  2017-10-02       Impact factor: 3.659

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.